Arvin Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-67,838	Closed	-$14M	–	22
2024 Q2	$14M	Buy	67,838 +18,157	+37%	+$3.75M	4.42%	7
2024 Q1	$13.5M	Buy	49,681 +29,620	+148%	+$8.03M	5.04%	7
2023 Q4	$4.74M	Buy	+20,061	New	+$4.74M	2.09%	17